REC — Recordati Industria Chimica E Farmaceutica SpA Share News
0.000.00%
Last trade - 00:00- €10.48bn
- €12.46bn
- €2.62bn
Top of the Street: NN Group, Symrise, Metso, Recordati
Jefferies ups Recordati to 'buy' on rare disease momentum, M&A upside
Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs
Brief: There will be 15% U.S. tariffs on pharma, exemption for rare diseases, Recordati CEO says
Italy - Factors to watch on July 30
Recordati's core profit rises, but sees bigger FX hit
Brief: Recordati H1 EBITDA EUR 496.3 Million
Brief: Recordati H1 Revenue EUR 1,323.8 Million
Brief: Recordati H1 EBITDA EUR 496.3 Mln
Italy - Factors to watch on July 29
Analysis: Five years after COVID, pharma shares languish in US policy limbo
Analysis: Five years after COVID, pharma shares languish in US policy limbo
Amarin gains on licensing deal with Italy's Recordati
Brief: Recordati Signs Exclusive Licensing & Supply Agreement With Amarin To Commercialize Vazkepa In Europe
J.P.Morgan reiterates 'overweight' on Recordati, notes 'fairly strong organic growth'
Europe Research Roundup: Aegon, AXA, Sonova Holding
Europe Research Roundup: E.ON, IHG, National Grid
Italy - Factors to watch on May 19
Brief: Recordati Q1 Free Cash Flow EUR 158.8 Million